Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rosiptor - Neoleukin Therapeutics

Drug Profile

Rosiptor - Neoleukin Therapeutics

Alternative Names: AQX 1125; Rosiptor acetate

Latest Information Update: 13 Aug 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aquinox Pharmaceuticals
  • Class Androstanes; Anti-inflammatories; Immunotherapies; Indenes; Small molecules
  • Mechanism of Action Inositol-1,4,5-trisphosphate 5-phosphatase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Allergic asthma; Atopic dermatitis; Chronic obstructive pulmonary disease; Haematological disorders; Hypersensitivity; Immunological disorders; Inflammation; Interstitial cystitis; Irritable bowel syndrome; Prostatitis; Pulmonary fibrosis

Most Recent Events

  • 09 Aug 2019 Aquinox Pharmaceuticals merged with Neoleukin therapeutics to form Neoleukin Therapeutics
  • 08 Aug 2018 Discontinued - Phase-II for Allergic asthma in United Kingdom, Canada (PO)
  • 08 Aug 2018 Discontinued - Phase-II for Prostatitis in Canada, USA (PO)
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top